Cargando…
Rare tumors research in emerging countries
Rare tumors, when considered as a group, represent a significant burden to society as they may account for up to 25% of the mortality by cancer in nations like the United States. In contrast with the current scenario in highly incident cancer types, little progress has been achieved in the treatment...
Autores principales: | Mano, Max S, Arai, Roberto J, Hoff, Paulo M.G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
PagePress
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994521/ https://www.ncbi.nlm.nih.gov/pubmed/21139964 http://dx.doi.org/10.4081/rt.2010.e49 |
Ejemplares similares
-
Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy
por: Arai, Roberto J., et al.
Publicado: (2018) -
Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy
por: Testa, Laura, et al.
Publicado: (2021) -
Education and training for medicines development, regulation, and clinical research in emerging countries
por: Kerpel-Fronius, Sandor, et al.
Publicado: (2015) -
Developing metrics for emergency care research in low- and middle-income countries
por: Abujaber, Samer, et al.
Publicado: (2016) -
Emergency care research ethics in low-income and middle-income countries
por: Millum, Joseph, et al.
Publicado: (2019)